The immunotoxic effects of acute, repetitive inhalation of pentavalent vanadium (7440622) in the rat lung were examined. Male Fischer-344-rats were exposed nose only to atmospheres of ammonium- metavanadate (7803556) (NH4VO3) at an occupationally relevant exposure level of 2mg/m3 as vanadium for 8 hours/day, for 4 days. Selected rats were killed immediately after each daily exposure, or 24 hours after the final exposure, for the analysis of lung burdens. The lungs were removed and prepared for graphite atomic absorption analysis. Immunotoxic effects were assessed by analysis of isolated rat pulmonary alveolar macrophages (PAMs), a tumor necrosis factor- alpha (TNF-alpha) production assay, measurements of ROI production in recovered lung cells, assessments of interferon gamma (IFN-gamma) induced I-A expression, and phagocytic activity of recovered cells. Lung analysis showed that inhalation of NH4VO3 at the studied exposure levels produced a significant time dependent increase in lung burden, with increases of 44% between the first 2 days of exposure, and 10% increases after that time. Exposed rats also exhibited increases in the absolute numbers and relative percentages of neutrophils and small macrophages. Significant increases in lactate-dehydrogenase activity and protein levels in the bronchoalveolar fluid suggested lung cell damage due to vanadium exposure. vanadium exposure also substantially inhibited the capacity of PAMs to generate TNF-alpha and ROI, actively phagocytize opsonized particles, and increase the surface expression of I-A antigen. The study results indicated that host pulmonary immunocompetence in rats can be altered by short term, repeated exposure to vanadium at occupationally relevant levels, with effects on cytokine related functions. The authors conclude that such changes may explain the documented increases in lung infections and cancers in workers with long term exposures to vanadium.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.